ClinicalTrials.govpublic full text
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
relapsed or refractory multiple myeloma, bcma, chimeric antigen receptor t cell, adoptive cell therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 919047
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.